Cargando…

Addition of lysophospholipids with large head groups to cells inhibits Shiga toxin binding

Shiga toxin (Stx), an AB(5) toxin, binds specifically to the neutral glycosphingolipid Gb3 at the cell surface before being transported into cells. We here demonstrate that addition of conical lysophospholipids (LPLs) with large head groups inhibit Stx binding to cells whereas LPLs with small head g...

Descripción completa

Detalles Bibliográficos
Autores principales: Ailte, Ieva, Lingelem, Anne Berit Dyve, Kavaliauskiene, Simona, Bergan, Jonas, Kvalvaag, Audun Sverre, Myrann, Anne-Grethe, Skotland, Tore, Sandvig, Kirsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960542/
https://www.ncbi.nlm.nih.gov/pubmed/27458147
http://dx.doi.org/10.1038/srep30336
_version_ 1782444541715939328
author Ailte, Ieva
Lingelem, Anne Berit Dyve
Kavaliauskiene, Simona
Bergan, Jonas
Kvalvaag, Audun Sverre
Myrann, Anne-Grethe
Skotland, Tore
Sandvig, Kirsten
author_facet Ailte, Ieva
Lingelem, Anne Berit Dyve
Kavaliauskiene, Simona
Bergan, Jonas
Kvalvaag, Audun Sverre
Myrann, Anne-Grethe
Skotland, Tore
Sandvig, Kirsten
author_sort Ailte, Ieva
collection PubMed
description Shiga toxin (Stx), an AB(5) toxin, binds specifically to the neutral glycosphingolipid Gb3 at the cell surface before being transported into cells. We here demonstrate that addition of conical lysophospholipids (LPLs) with large head groups inhibit Stx binding to cells whereas LPLs with small head groups do not. Lysophosphatidylinositol (LPI 18:0), the most efficient LPL with the largest head group, was selected for in-depth investigations to study how the binding of Stx is regulated. We show that the inhibition of Stx binding by LPI is reversible and possibly regulated by cholesterol since addition of methyl-β-cyclodextrin (mβCD) reversed the ability of LPI to inhibit binding. LPI-induced inhibition of Stx binding is independent of signalling and membrane turnover as it occurs in fixed cells as well as after depletion of cellular ATP. Furthermore, data obtained with fluorescent membrane dyes suggest that LPI treatment has a direct effect on plasma membrane lipid packing with shift towards a liquid disordered phase in the outer leaflet, while lysophosphoethanolamine (LPE), which has a small head group, does not. In conclusion, our data show that cellular treatment with conical LPLs with large head groups changes intrinsic properties of the plasma membrane and modulates Stx binding to Gb3.
format Online
Article
Text
id pubmed-4960542
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-49605422016-08-05 Addition of lysophospholipids with large head groups to cells inhibits Shiga toxin binding Ailte, Ieva Lingelem, Anne Berit Dyve Kavaliauskiene, Simona Bergan, Jonas Kvalvaag, Audun Sverre Myrann, Anne-Grethe Skotland, Tore Sandvig, Kirsten Sci Rep Article Shiga toxin (Stx), an AB(5) toxin, binds specifically to the neutral glycosphingolipid Gb3 at the cell surface before being transported into cells. We here demonstrate that addition of conical lysophospholipids (LPLs) with large head groups inhibit Stx binding to cells whereas LPLs with small head groups do not. Lysophosphatidylinositol (LPI 18:0), the most efficient LPL with the largest head group, was selected for in-depth investigations to study how the binding of Stx is regulated. We show that the inhibition of Stx binding by LPI is reversible and possibly regulated by cholesterol since addition of methyl-β-cyclodextrin (mβCD) reversed the ability of LPI to inhibit binding. LPI-induced inhibition of Stx binding is independent of signalling and membrane turnover as it occurs in fixed cells as well as after depletion of cellular ATP. Furthermore, data obtained with fluorescent membrane dyes suggest that LPI treatment has a direct effect on plasma membrane lipid packing with shift towards a liquid disordered phase in the outer leaflet, while lysophosphoethanolamine (LPE), which has a small head group, does not. In conclusion, our data show that cellular treatment with conical LPLs with large head groups changes intrinsic properties of the plasma membrane and modulates Stx binding to Gb3. Nature Publishing Group 2016-07-26 /pmc/articles/PMC4960542/ /pubmed/27458147 http://dx.doi.org/10.1038/srep30336 Text en Copyright © 2016, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Ailte, Ieva
Lingelem, Anne Berit Dyve
Kavaliauskiene, Simona
Bergan, Jonas
Kvalvaag, Audun Sverre
Myrann, Anne-Grethe
Skotland, Tore
Sandvig, Kirsten
Addition of lysophospholipids with large head groups to cells inhibits Shiga toxin binding
title Addition of lysophospholipids with large head groups to cells inhibits Shiga toxin binding
title_full Addition of lysophospholipids with large head groups to cells inhibits Shiga toxin binding
title_fullStr Addition of lysophospholipids with large head groups to cells inhibits Shiga toxin binding
title_full_unstemmed Addition of lysophospholipids with large head groups to cells inhibits Shiga toxin binding
title_short Addition of lysophospholipids with large head groups to cells inhibits Shiga toxin binding
title_sort addition of lysophospholipids with large head groups to cells inhibits shiga toxin binding
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960542/
https://www.ncbi.nlm.nih.gov/pubmed/27458147
http://dx.doi.org/10.1038/srep30336
work_keys_str_mv AT ailteieva additionoflysophospholipidswithlargeheadgroupstocellsinhibitsshigatoxinbinding
AT lingelemanneberitdyve additionoflysophospholipidswithlargeheadgroupstocellsinhibitsshigatoxinbinding
AT kavaliauskienesimona additionoflysophospholipidswithlargeheadgroupstocellsinhibitsshigatoxinbinding
AT berganjonas additionoflysophospholipidswithlargeheadgroupstocellsinhibitsshigatoxinbinding
AT kvalvaagaudunsverre additionoflysophospholipidswithlargeheadgroupstocellsinhibitsshigatoxinbinding
AT myrannannegrethe additionoflysophospholipidswithlargeheadgroupstocellsinhibitsshigatoxinbinding
AT skotlandtore additionoflysophospholipidswithlargeheadgroupstocellsinhibitsshigatoxinbinding
AT sandvigkirsten additionoflysophospholipidswithlargeheadgroupstocellsinhibitsshigatoxinbinding